Annual Working Capital
$255.49 M
-$21.23 M-7.67%
December 31, 2023
Summary
- As of February 7, 2025, TERN annual working capital is $255.49 million, with the most recent change of -$21.23 million (-7.67%) on December 31, 2023.
- During the last 3 years, TERN annual working capital has risen by +$187.44 million (+275.45%).
- TERN annual working capital is now -7.67% below its all-time high of $276.72 million, reached on December 31, 2022.
Performance
TERN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$365.09 M
+$145.81 M+66.49%
September 30, 2024
Summary
- As of February 7, 2025, TERN quarterly working capital is $365.09 million, with the most recent change of +$145.81 million (+66.49%) on September 30, 2024.
- Over the past year, TERN quarterly working capital has increased by +$109.61 million (+42.90%).
- TERN quarterly working capital is now at all-time high.
Performance
TERN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TERN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.7% | +42.9% |
| 3 y3 years | +275.4% | +42.9% |
| 5 y5 years | +196.7% | +42.9% |
TERN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.7% | +59.6% | at high | +167.4% |
| 5 y | 5-year | -7.7% | +1379.0% | at high | +2997.1% |
| alltime | all time | -7.7% | +1379.0% | at high | +2997.1% |
Terns Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $365.09 M(+66.5%) |
| Jun 2024 | - | $219.28 M(-7.5%) |
| Mar 2024 | - | $237.07 M(-7.2%) |
| Dec 2023 | $255.49 M(-7.7%) | $255.49 M(-1.1%) |
| Sep 2023 | - | $258.37 M(-5.7%) |
| Jun 2023 | - | $274.08 M(-4.7%) |
| Mar 2023 | - | $287.56 M(+3.9%) |
| Dec 2022 | $276.72 M | $276.72 M(+51.2%) |
| Sep 2022 | - | $183.06 M(+34.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $136.56 M(-7.7%) |
| Mar 2022 | - | $147.95 M(-7.6%) |
| Dec 2021 | $160.11 M(+135.3%) | $160.11 M(-6.9%) |
| Sep 2021 | - | $171.90 M(-5.1%) |
| Jun 2021 | - | $181.05 M(-4.5%) |
| Mar 2021 | - | $189.66 M(+178.7%) |
| Dec 2020 | $68.05 M(+293.9%) | $68.05 M(-640.0%) |
| Sep 2020 | - | -$12.60 M(-173.0%) |
| Dec 2019 | $17.27 M(-79.9%) | $17.27 M |
| Dec 2018 | $86.10 M | - |
FAQ
- What is Terns Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual working capital year-on-year change?
- What is Terns Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly working capital year-on-year change?
What is Terns Pharmaceuticals annual working capital?
The current annual working capital of TERN is $255.49 M
What is the all time high annual working capital for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual working capital is $276.72 M
What is Terns Pharmaceuticals annual working capital year-on-year change?
Over the past year, TERN annual working capital has changed by -$21.23 M (-7.67%)
What is Terns Pharmaceuticals quarterly working capital?
The current quarterly working capital of TERN is $365.09 M
What is the all time high quarterly working capital for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly working capital is $365.09 M
What is Terns Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, TERN quarterly working capital has changed by +$109.61 M (+42.90%)